Kolon Biotech, a key player within the Kolon Group, offers over 20 years of expertise in Cell&Gene and Exosome therapy. Our state-of-the-art facilities and proven track record make us a trusted CDMO partner. 

Why Kolon Biotech? 

• Manufacturing Facilities: Optimized in manufacturing advanced biopharmaceuticals with over 20 years of experience for Cell & Gene therapy. B1 Plant located in Chung-Ju, South Korea is for GMP Clinical trials and Early commercialization, while B2 plant is specialized in mass production for commercial.

• Tailored Services: With extensive experience in various cell types including somatic cells, stem cells, immune cells, and iPSCs, we provide end-to-end services with cGMP regulation. For the product development, we can support the Cell Banking and pre-clinical batch production. In the early stages of clinical development, we support clients to achieve their R&D milestones at reasonable costs. In the late stages of pipeline development, we provide expertise to secure cost effectiveness and production efficiency to achieve successful commercialization. With fast production timeline with client’s development plan, we can deliver a Tox batch within 3.5 months from project initiation and supply Investigational Products within 6 months.

• Track Records: A global leader with abundant experiences in producing cell therapies. We have successfully produced over 100 commercial batches in South Korea. We also have multiple IND submissions to MFDS and FDA. Our ongoing expansion into Japan and USA demonstrates our international reliability and competitiveness. We aim to achieve successful readiness of commercial production facility by 2025.

• Innovative Technologies

        ► 2D Automated Closed Platform: Ensures minimal human error. 

        ► 3D Bioreactor Process: Maximizes productivity and scalability. 

For more information, please meet us at Booth M 435 in Overseas Pavilion.

Moreover, you can visit our website (KOLON BIOTECH) and watch our promotional video (KOLON BIOTECH: Shaping the Future as a Global cell therapy CDMO and exosome therapy CDMO (youtube.com).